# Novolin R

NDC: 0169-3003
Generic name: Human Insulin
Labeler / Manufacturer: Novo Nordisk
Product type: HUMAN OTC DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20190906

FDA application: BLA019938

## Active ingredients

- INSULIN HUMAN: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-3003"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-3003
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aee7f1f3-612c-4027-8ce9-4fd1f41eed71